Literature DB >> 27597289

Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety".

Joshua M Bauml1, Andrea Troxel2, C Neill Epperson3, Roger B Cohen4, Kathryn Schmitz5, Carrie Stricker6, Lawrence N Shulman4, Angela Bradbury4, Jun J Mao7, Corey J Langer4.   

Abstract

OBJECTIVES: Diagnostic imaging may be a major source of cancer-related distress, a condition known as "scanxiety". Scant scholarly work has been performed to evaluate scan-associated distress in cancer. We sought to characterize risk factors for scan-associated distress among patients with Non-Small Cell Lung Cancer (NSCLC), and to evaluate the impact of scan-associated distress on quality of life.
MATERIALS AND METHODS: We conducted a cross-sectional survey study of patients with recurrent/metastatic NSCLC treated at an academic medical center. Clinical and demographic variables were obtained through chart abstraction and patient self-report. We used a modified version of the Impact of Event Scale 6 (IES-6) to specifically assess distress associated with scans, and quality of life was measured using the Functional Assessment of Cancer Therapy - Lung (FACT-L).
RESULTS: Among 103 participants (survey response rate 76.3%), median age was 67, 61.2% were women, and 82.5% were white. At the study visit, 72.8% of subjects discussed a recent scan, and 83% reported some scan-associated distress. Scan-associated distress was not associated with whether the patient had a recent scan, progressive disease or time from diagnosis. Scan-associated distress was associated with impaired quality of life (p=0.004); each unit increase in IES-6 corresponded to an approximately one-unit decrease in FACT-L score.
CONCLUSION: Scan-associated distress is a common problem among patients with NSCLC, and is associated with impaired quality of life. Scan-associated distress severity was not associated with time since diagnosis or whether a recent scan was discussed at the study visit, which implies scan-associated distress may be a persistent problem. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Cancer distress; Lung cancer; Quality of life; Scan-associated distress; Scanxiety

Mesh:

Year:  2016        PMID: 27597289      PMCID: PMC5646232          DOI: 10.1016/j.lungcan.2016.08.002

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  29 in total

1.  Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Hannah Arem; Ruth M Pfeiffer; Eric A Engels; Catherine M Alfano; Albert Hollenbeck; Yikyung Park; Charles E Matthews
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

Review 2.  Screening for cancer-related distress: Summary of evidence from tools to programmes.

Authors:  Pernille Envold Bidstrup; Christoffer Johansen; Alex J Mitchell
Journal:  Acta Oncol       Date:  2011-02       Impact factor: 4.089

3.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

Review 4.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

5.  Effect of abnormal screening mammogram on quality of life.

Authors:  A F W van der Steeg; C M G Keyzer-Dekker; J De Vries; J A Roukema
Journal:  Br J Surg       Date:  2010-12-20       Impact factor: 6.939

6.  Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial.

Authors:  K A M van den Bergh; M L Essink-Bot; G J J M Borsboom; E T Scholten; R J van Klaveren; H J de Koning
Journal:  Eur Respir J       Date:  2010-12-09       Impact factor: 16.671

7.  Screening for distress in lung and breast cancer outpatients: a randomized controlled trial.

Authors:  Linda E Carlson; Shannon L Groff; Olga Maciejewski; Barry D Bultz
Journal:  J Clin Oncol       Date:  2010-10-12       Impact factor: 44.544

8.  Quality of life in adult survivors of lung, colon and prostate cancer.

Authors:  C A Schag; P A Ganz; D S Wing; M S Sim; J J Lee
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

9.  Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.

Authors:  Gregory J Riely; William Pao; Duykhanh Pham; Allan R Li; Naiyer Rizvi; Ennapadam S Venkatraman; Maureen F Zakowski; Mark G Kris; Marc Ladanyi; Vincent A Miller
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

10.  Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial.

Authors:  Louise Mosborg Aggestrup; Mie Sara Hestbech; Volkert Siersma; Jesper Holst Pedersen; John Brodersen
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

View more
  26 in total

1.  Preferences for notification of imaging results in patients with metastatic cancer.

Authors:  Mary K Morreale; Tanina F Moore; Seongho Kim; Heatherlun S Uphold; Lorna M Mabunda; Felicity W K Harper
Journal:  Patient Educ Couns       Date:  2019-08-22

2.  The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass.

Authors:  David Malkin; Kim E Nichols; Joshua D Schiffman; Sharon E Plon; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-11-01       Impact factor: 12.531

3.  Association Between Symptomatic Versus Asymptomatic Recurrence and Survival in Bladder Cancer.

Authors:  Chelsea K Osterman; Jaber Alanzi; James D Lewis; Elizabeth L Kaufman; Vivek Narayan; Ben Boursi; Ravy K Vajravelu; Frank I Scott; S Bruce Malkowicz; Ronac Mamtani
Journal:  Clin Genitourin Cancer       Date:  2017-12-06       Impact factor: 2.872

4.  The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors.

Authors:  Julia Lai-Kwon; Chloe Khoo; Serigne Lo; Donna Milne; Mustafa Mohamed; Jeanette Raleigh; Kortnye Smith; Karolina Lisy; Shahneen Sandhu; Michael Jefford
Journal:  J Cancer Surviv       Date:  2019-06-04       Impact factor: 4.442

Review 5.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

6.  Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients.

Authors:  Heather M Derry; Paul K Maciejewski; Andrew S Epstein; Manish A Shah; Thomas W LeBlanc; Valerie Reyna; Holly G Prigerson
Journal:  J Palliat Med       Date:  2019-02-06       Impact factor: 2.947

Review 7.  Use of virtual reality for symptom management in solid-tumor patients with implications for primary brain tumor research: a systematic review.

Authors:  Nicole M Leggiero; Terri S Armstrong; Mark R Gilbert; Amanda L King
Journal:  Neurooncol Pract       Date:  2020-03-28

8.  Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey.

Authors:  Kim Tam Bui; Belinda E Kiely; Haryana M Dhillon; Chris Brown; Kay Xu; Mohsen Shafiei; Prunella Blinman
Journal:  Support Care Cancer       Date:  2021-08-01       Impact factor: 3.603

9.  Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study.

Authors:  James L Rogers; Elizabeth Vera; Alvina Acquaye; Nicole Briceno; Varna Jammula; Amanda L King; Heather Leeper; Martha M Quezado; Javier Gonzalez Alarcon; Lisa Boris; Eric Burton; Orieta Celiku; Anna Choi; Alexa Christ; Sonja Crandon; Ewa Grajkowska; Nicole Leggiero; Nicole Lollo; Marta Penas-Prado; Jennifer Reyes; Christine Siegel; Brett J Theeler; Michael Timmer; Kathleen Wall; Jing Wu; Kenneth Aldape; Mark R Gilbert; Terri S Armstrong
Journal:  Neurooncol Pract       Date:  2021-04-10

Review 10.  Scanxiety: a scoping review about scan-associated anxiety.

Authors:  Kim Tam Bui; Roger Liang; Belinda E Kiely; Chris Brown; Haryana M Dhillon; Prunella Blinman
Journal:  BMJ Open       Date:  2021-05-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.